Download PDFPDF

Tissue-specific insulin resistance
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Re: Alas, Alas, Animal Models!


    There is a very sad account of the fatal consequences of extrapolation of animal findings to humans, "recent experience with fialuridin ... five out of 15 patients died, two required emergency liver and kidney transplant for liver and kidney failure-this effect had not been demonstrated in four animal species."[1] This is a very sobering account of the consequences of extrapolating animal findings to humans....

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Alas, Alas, Animal Models!

    Dear Editor

    Jackson raises a point that is indeed relevant, and I fully agree that premature extrapolations to human therapeutics are dangerous.[1] If animals were all horses, wishes would fly! These animal studies only provide a glimpse into new possibilities and futuristic ideas. I am concerned about any other interpretation, and my opinion too is that, for the present, these findings cannot be translated into da...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Alas animal models
    Dear Editor

    Is it feasible to extrapolate animal findings to human medicine? We did not evolve (see ). These chromosome numbers certainly do not support any evolutionary suppositions. Furthermore the mechanisms of meiosis serve to "fix" the chromosome numbers of sexually reproducing species. Is it not, therefore, dange...

    Show More
    Conflict of Interest:
    None declared.